XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Jul. 31, 2022
Jan. 31, 2022
Current assets:    
Cash and cash equivalents $ 187,662,000 $ 315,235,000
Restricted cash 400,000 400,000
Short-term investments 283,880,000 0
Accounts receivable, net of allowance of $6,731 as of July 31, 2022 and $5,584 as of January 31, 2022 109,922,000 75,939,000
Inventories 53,420,000 35,879,000
Prepaid expenses and other current assets 44,902,000 36,603,000
Total current assets 680,186,000 464,056,000
Property and equipment, net 36,699,000 34,593,000
Intangible assets, net 94,482,000 107,209,000
Operating lease right-of-use assets 22,571,000 25,535,000
Goodwill 205,580,000 218,484,000
Other assets 6,512,000 6,020,000
Total assets 1,046,030,000 855,897,000
Current liabilities:    
Accounts payable 45,145,000 27,576,000
Accrued and other current liabilities 110,096,000 84,328,000
Deferred revenue 83,529,000 77,142,000
Total current liabilities 238,770,000 189,046,000
Deferred revenue, noncurrent 84,052,000 69,666,000
Debt, noncurrent 294,334,000 0
Operating lease liabilities 22,727,000 25,370,000
Deferred tax liabilities 13,383,000 17,697,000
Other long-term liabilities 1,075,000 7,104,000
Total liabilities 654,341,000 308,883,000
Commitments and contingencies (Note 9)
Stockholders’ equity (deficit):    
Common stock: $0.0001 par value; 1,000,000,000 shares authorized as of July 31, 2022 and January 31, 2022; 338,820,463 and 334,760,615 shares issued and outstanding as of July 31, 2022 and January 31, 2022, respectively 34,000 33,000
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of July 31, 2022 and January 31, 2022; 0 issued and outstanding as of July 31, 2022 and January 31, 2022 0 0
Additional paid-in capital 1,414,301,000 1,366,855,000
Accumulated other comprehensive loss (29,025,000) (8,219,000)
Accumulated deficit (993,621,000) (811,655,000)
Total stockholders’ equity 391,689,000 547,014,000
Total liabilities and stockholders’ equity $ 1,046,030,000 $ 855,897,000